LOGIN  |  REGISTER
Recursion
C4 Therapeutics

FDA Roundup: August 25, 2023

Silver Spring, MD / August 25, 2023 /  Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: 

  • Today, the FDA announced the signing of a first-of-its kind Regulatory Partnership Arrangement with Ecuador’s seafood regulatory authority to enhance the safety of shrimp imported to the United States.

  • On Thursday, the FDA issued a proposed External Link Disclaimer rule to revise the standard of identity and standard of fill of container for canned tuna. The proposed rule responds, in part, to a citizen petition External Link Disclaimer submitted by Bumble Bee Foods, LLC, StarKist Co., and Tri Union Seafoods, LLC (dba Chicken of the Sea International).

  • On Wednesday, the FDA updated Safely Treating Molluscum, a Common Skin Condition with information for consumers on a new drug approval. There is only one FDA-approved treatment for molluscum, called Ycanth (cantharidin), which must be administered by a health care professional. The FDA has not approved any nonprescription products to treat molluscum.

  • On Wednesday, the FDA issued warning letters to 15 online retailers for selling and/or distributing unauthorized e-cigarette products packaged to look like youth-appealing characters, school supplies, toys, and drinks. Since the appearance of these illegal products can be deceiving, the agency is also seeking to raise awareness among parents, teachers, and other adults headed into the new school year.

  • On Tuesday, the FDA updated Hurricane Season: Be Prepared with additional information and resources for consumers. September is National Preparedness Month and is a great time to review recommendations, emergency kits, and rotate/replace items that may be expired so individuals are prepared for disasters and emergencies, which can happen at any time.

###

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

 

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB